Theravance Biopharma (TBPH) Short Interest Ratio & Short Volume → Biden’s $374B Giveaway Into This Sector (From DTI) (Ad) Free TBPH Stock Alerts $9.20 -0.32 (-3.36%) (As of 04/18/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Theravance Biopharma Short Interest DataCurrent Short Volume7,520,000 sharesPrevious Short Volume8,400,000 sharesChange Vs. Previous Month-10.48%Dollar Volume Sold Short$67.45 millionShort Interest Ratio / Days to Cover20.3Last Record DateMarch 31, 2024Outstanding Shares48,560,000 sharesFloat Size43,830,000 sharesShort Percent of Float17.16%Today's Trading Volume362,260 sharesAverage Trading Volume399,537 sharesToday's Volume Vs. Average91% Short Selling Theravance Biopharma ? Sign up to receive the latest short interest report for Theravance Biopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatTBPH Short Interest Over TimeTBPH Days to Cover Over TimeTBPH Percentage of Float Shorted Over Time Ad DTIBiden’s $374B Giveaway Into This SectorBiden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereClick here for the full story Theravance Biopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20247,520,000 shares $67.45 million -10.5%17.2%20.3 $8.97 3/15/20248,400,000 shares $72.58 million -2.4%18.9%23.1 $8.64 2/29/20248,610,000 shares $81.54 million -2.8%19.4%22.7 $9.47 2/15/20248,860,000 shares $76.82 million +6.2%19.3%22.6 $8.67 1/31/20248,340,000 shares $79.06 million -2.3%18.2%20.4 $9.48 1/15/20248,540,000 shares $83.95 million -4.2%18.6%20.8 $9.83 Get the Latest News and Ratings for TBPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Theravance Biopharma and its competitors with MarketBeat's FREE daily newsletter. 12/31/20238,910,000 shares $100.15 million -4.4%19.4%21.5 $11.24 12/15/20239,320,000 shares $102.43 million -0.1%20.3%23.2 $10.99 11/30/20239,330,000 shares $97.78 million +2.8%20.2%21.8 $10.48 11/15/20239,080,000 shares $92.89 million +1.3%19.7%21.5 $10.23 10/31/20238,960,000 shares $84.58 million -0.4%18.3%20.4 $9.44 10/15/20239,000,000 shares $81.54 million +1.9%18.4%21 $9.06 9/30/20238,830,000 shares $76.20 million -2.7%19.7%20.4 $8.63 9/15/20239,070,000 shares $81.63 million +0.8%20.3%19.8 $9.00 8/31/20239,000,000 shares $85.68 million No Change19.8%19.4 $9.52 8/15/20239,000,000 shares $91.26 million +8.2%19.8%18.6 $10.14 7/31/20238,320,000 shares $82.28 million +1.0%16.7%16.2 $9.89 7/15/20238,240,000 shares $80.67 million +0.2%16.6%15.4 $9.79 6/30/20238,220,000 shares $85.08 million -6.2%16.5%14.3 $10.35 6/15/20238,760,000 shares $91.02 million +0.2%17.6%14.7 $10.39 5/31/20238,740,000 shares $97.71 million +3.2%17.4%16 $11.18 5/15/20238,470,000 shares $95.37 million +9.2%16.9%14.9 $11.26 4/30/20237,760,000 shares $84.04 million +1.8%14.2%14.8 $10.83 4/15/20237,620,000 shares $90.83 million +5.5%14.0%15.3 $11.92 3/31/20237,220,000 shares $78.34 million -4.9%13.1%14.2 $10.85 3/15/20237,590,000 shares $80.15 million -6.4%14.1%15.8 $10.56 2/28/20238,110,000 shares $87.59 million -5.0%15.1%16.9 $10.80 2/15/20238,540,000 shares $88.13 million -3.5%14.7%17.4 $10.32 1/31/20238,850,000 shares $95.67 million +2.1%15.2%13.7 $10.81 1/15/20238,670,000 shares $97.97 million +3.6%14.8%12.5 $11.30 12/30/20228,370,000 shares $93.91 million +1.7%14.3%11.5 $11.22 12/15/20228,230,000 shares $89.05 million +3.4%14.0%10.7 $10.82 11/30/20227,960,000 shares $85.65 million +3.1%13.6%10.2 $10.76 11/15/20227,720,000 shares $87.47 million +3.6%13.3%10.1 $11.33 10/31/20227,450,000 shares $74.28 million -1.2%12.9%11.3 $9.97 10/15/20227,540,000 shares $74.80 million -2.3%13.0%12.4 $9.92 9/30/20227,720,000 shares $78.28 million +2.9%N/A7.6 $10.14 9/15/20227,500,000 shares $75.38 million -3.0%N/A7.9 $10.05 8/31/20227,730,000 shares $69.65 million No Change13.9%8.6 $9.01 8/15/20227,730,000 shares $74.98 million +3.5%13.9%8.4 $9.70Biden’s $374B Giveaway Into This Sector (Ad)Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereClick here for the full story TBPH Short Interest - Frequently Asked Questions What is Theravance Biopharma's current short interest? Short interest is the volume of Theravance Biopharma shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 7,520,000 shares of TBPH short. 17.16% of Theravance Biopharma's shares are currently sold short. Learn More on Theravance Biopharma's current short interest. What is a good short interest ratio for Theravance Biopharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TBPH shares currently have a short interest ratio of 20.0. Learn More on Theravance Biopharma's short interest ratio. Which institutional investors are shorting Theravance Biopharma? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Theravance Biopharma: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Theravance Biopharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 17.16% of Theravance Biopharma's floating shares are currently sold short. Is Theravance Biopharma's short interest increasing or decreasing? Theravance Biopharma saw a decrease in short interest in March. As of March 31st, there was short interest totaling 7,520,000 shares, a decrease of 10.5% from the previous total of 8,400,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Theravance Biopharma's float size? Theravance Biopharma currently has issued a total of 48,560,000 shares. Some of Theravance Biopharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Theravance Biopharma currently has a public float of 43,830,000 shares. How does Theravance Biopharma's short interest compare to its competitors? 17.16% of Theravance Biopharma's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Theravance Biopharma: Travere Therapeutics, Inc. (13.93%), Larimar Therapeutics, Inc. (5.00%), Annexon, Inc. (3.99%), Fulcrum Therapeutics, Inc. (3.65%), Avid Bioservices, Inc. (15.99%), Mersana Therapeutics, Inc. (8.35%), Oculis Holding AG (0.17%), Neurogene Inc. (7.87%), Heron Therapeutics, Inc. (17.00%), KalVista Pharmaceuticals, Inc. (13.08%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Theravance Biopharma stock? Short selling TBPH is an investing strategy that aims to generate trading profit from Theravance Biopharma as its price is falling. TBPH shares are trading down $0.32 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Theravance Biopharma? A short squeeze for Theravance Biopharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TBPH, which in turn drives the price of the stock up even further. How often is Theravance Biopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TBPH, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: TVTX Short Interest Data LRMR Short Interest Data ANNX Short Interest Data FULC Short Interest Data CDMO Short Interest Data MRSN Short Interest Data OCS Short Interest Data NGNE Short Interest Data HRTX Short Interest Data KALV Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TBPH) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTIForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchUrgent alert: open this for a huge profit potentialTimothy SykesThe #1 Crypto for 2024InvestorPlace